Pharma Friday – September 18, 2026
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Bayer’s KERENDIA® (finerenone) Receives FDA Approval as the First New Treatment in 30 Years for Adults with Chronic Kidney Disease (CKD) and Type 1 Diabetes KERENDIA® (finerenone), a non-steroidal mineralocorticoid receptor antagonist (MRA), is the first new treatment in more than 30 years […]
The post Pharma Friday – September 18, 2026 appeared first on Endocrine News.
Apa Reaksi Anda?
Suka
0
Kurang Suka
0
Setuju
0
Tidak Setuju
0
Bagus
0
Berguna
0
Hebat
0
